Tumor necrosis factor-alpha: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New page: {{subpages}} In medicine, '''tumor necrosis factor-alpha''' is a "serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes. It has necrotizing ac...) |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
In [[medicine]], '''tumor necrosis factor-alpha''' is a "serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as ''' | In [[medicine]], '''tumor necrosis factor-alpha''' is a "serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as '''TNF-alpha''', it is only 30% homologous to tnf-beta (lymphotoxin), but they share [[tumor necrosis factor receptor|TNF receptors]].<ref>{{MeSH}}</ref> | ||
TNFR-Fc fusion protein (etanercept - pronounced et a ner' set) blocks the activity of TNF-alpha.<ref>{{MedMaster|Etanercept}}</ref> | |||
==References== | ==References== | ||
<references/> | <references/> | ||
Revision as of 15:15, 1 September 2008
In medicine, tumor necrosis factor-alpha is a "serum glycoprotein produced by activated macrophages and other mammalian mononuclear leukocytes. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to tnf-beta (lymphotoxin), but they share TNF receptors.[1]
TNFR-Fc fusion protein (etanercept - pronounced et a ner' set) blocks the activity of TNF-alpha.[2]
References
- ↑ Anonymous (2024), Tumor necrosis factor-alpha (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Template:MedMaster